Tuberculosis treatment delivery in high burden settings: Does patient choice of supervision matter?

International Journal of Tuberculosis and Lung Disease

Volumn 6, Issue 7, 2002, Pages 599-608

  Kironde, Samson ^a,b   Meintjies, M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Department of Health ^*  (South Africa)

Author keywords

DOT; High burden settings; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DECISION MAKING; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOUTH AFRICA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUBERCULOSIS; AGED; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG SELF ADMINISTRATION; LUNG TUBERCULOSIS; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT COMPLIANCE;

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHOICE BEHAVIOR; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SELF ADMINISTRATION; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 0036635210     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Murray C J L, Styblo K, Rouillon A. Tuberculosis in developing countries; burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65: 2-20.
2. Narain J P, Raviglione M C, Kochi A. HIV associated tuberculosis in developing countries; epidemiology and strategies for prevention. Tubercle Lung Dis 1992; 73: 311-321.
3. Dolin P J, Raviglione M C, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72: 212-220.
4. Kochi A. Tuberculosis: distribution, risk factors, mortality. Immunobiol 1994; 191: 325-336.
5. Grange J M, Zumla A. Tuberculosis - an epidemic of injustice. J R Coll Physicians, London 1997; 31: 637-639.
6. Elliot A M, Luo N, Tembo G, et al. Impact of HIV on tuberculosis in Zambia: a cross-sectional study. BMJ 1990; 301: 412-415.
7. Eriki P P, Okwera A, Aisu T, et al. The influence of human immunodeficiency virus on tuberculosis in Kampala. Am Rev Res Dis 1991; 143: 185-187.
8. Harries A D. The association between HIV and tuberculosis in the developing world. In: Davies P D O, ed. Clinical Tuberculosis. Chapman and Hall, 1994: pp 241-264.
9. De Cock K M, Wilkinson D. Tuberculosis control in resource-poor countries: alternative approaches in the era of HIV. Lancet 1995; 346: 675-677.
10. Karim S S A. HIV and tuberculosis [Letter]. Lancet 1998; 349: 1542-1543.
11. World Health Organization. Tuberculosis framework for tuberculosis control. WHO/TB/94.179. Geneva: WHO, 1994.
12. Cuneo W D, Snider D E. Enhancing patient compliance with tuberculosis therapy. Clin Chest Med 1989; 10: 375-380.
13. Squire B S, Wilkinson D. Strengthening "DOTS" through community care for tuberculosis [Letter]. BMJ 1997; 315: 1395-1396.
14. Dick J, Clarke M, Tibbs J, Schoeman H. Combating tuberculosis - lessons learnt from a rural community project in the Klein Drakenstein area of the Western Cape. S Afr Med J 1997; 87: 1042-1047.
15. Sumartojo E. When tuberculosis treatment fails. A social behavioural account of patient adherence. Am Rev Res Dis 1993; 147: 1311-1320.
16. World Health Organization. Global Tuberculosis Programme, Global Tuberculosis Control - WHO Report 2000. WHO/CDS/TB/2000.275. Geneva: WHO, 2000.
17. Kironde S. Tuberculosis. In: Ntuli A, Crisp N, Clarke E, Baron P, eds. South African Health Review. Durban: Health Systems Trust. 2000: pp 335-349.
18. The South African National Tuberculosis Control Programme. Practical Guidelines 2000. Cape Town, South Africa: Department of Health, 2000.
19. Harper I. Is universal daily DOT essential? [Online] Available: http://www.tbnet.np/forum/issuel.htm [Accessed 24th April 2001].
20. Walley J, Khan A, Newell J, Khan H. Directly observed treatment-short course (DOTS) for tuberculosis: a randomised controlled trial in Pakistan shows no additional benefit from direct observation. Lancet 2001; 357: 664-669.
21. World Health Organization. Tuberculosis Control in South Africa: Joint Programme Review 1996. WHO/TB/96.208. Geneva: WHO, 1996.
22. Zwarenstein M, Schoeman J H, Vundule C, Lombard C J, Tatley M. Randomised controlled trial of self supervised and directly observed treatment for tuberculosis. Lancet 1998; 352: 1340-1343.
23. Volmink J, Matchaba P, Garner P. Directly observed therapy and treatment adherence. Lancet 2000; 355: 1345-1350.
24. Kamolratanakul P, Sawert H, Lertmaharit S, et al. Randomised controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Trans R Soc Trop Med Hyg 1999; 93: 552-557.
25. Frieden T R. Directly observed treatment for tuberculosis [Letter]. Lancet 1999; 353: 146.
26. Perlman D C, Salomon N. Directly observed therapy and treatment adherence [Letter]. Lancet 2000; 356: 1030.
27. Lönnrotth K. Public health in private hands: studies on private and public tuberculosis care in Ho Chi Minh City, Vietnam. Göteborg, Sweden: Parajett, Londskrona, 2000.
28. Fujiwara P I, Larkin C, Frieden R T. Directly observed therapy in New York City. Clin Chest Med 1997; 347: 135-148.
29. Davidson B L. A controlled comparison of directly observed therapy vs. self-administered therapy for active tuberculosis in the urban United States. Chest 1998; 114: 1239-1243.
30. Pozsik C, Kinney J, Breeden D et al. Approaches to improving adherence to antituberculosis therapy - South Carolina and New York, 1986-1992. MMWR 1993; 42: 74-81.
31. Smirnoff M, Goldberg R, Indyk L, Alder J J. Directly observed therapy in an inner city hospital. Int J Tuberc Lung Dis 1998; 2: 44-51.
32. Kironde S. Implementing community-based tuberculosis treatment in the Northern Cape province in South Africa - an emerging model for high incidence areas in Africa? Doctoral Thesis. Oxford, UK: Oxford University, 2001.
33. Perriens J H, Coleblunders R L, Karahunga C, et al. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with 'standard' chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis 1991; 144: 750-755.
34. Nunn P, Gichecha C, Hayes R, et al. Cross-sectional survey of HIV infection among patients with tuberculosis in Nairobi, Kenya. Tubercle Lung Dis 1992; 73: 45-51.
35. De Cock K M. Tuberculosis control in resource-poor settings with high rates of HIV infection. Am J Public Health 1996; 86: 1071-1073.
36. Raviglione M C, Dye C, Schmidt S, Kochi A. Assessment of worldwide tuberculosis control. Lancet 1997; 350: 624-629.
37. De Cock K M, Chaisson R E. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis 1999; 3: 457-465.
38. Fourie P B, Weyer K. A noxious synergy - Tuberculosis and HIV in South Africa. MRC Press Release 2000. [Online] Available: http://www.mrc.ac.za/pressrel/2000/7press2000.html. [Accessed 18th April 2000].